Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Combining systemic and topical treatments, guided by weekly fungal cultures, effectively treats cat ringworm.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Hair loss in lupus patients indicates higher disease activity.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

PCR-ELISA is better for identifying the fungus causing scalp infections in Ugandan children than traditional methods.

Researchers developed a model that shows hair follicles increase skin absorption of caffeine by 20%.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Lupus can cause hair loss and nail changes, with treatments available for both.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Phenobarbitone can cause severe and sometimes fatal skin reactions.